Literature DB >> 11980955

PreservCyt transport medium used for the ThinPrep Pap test is a suitable medium for detection of Chlamydia trachomatis by the COBAS Amplicor CT/NG test: results of a preliminary study and future implications.

Anne Bianchi1, François Moret, Jean-Marc Desrues, Thierry Champenois, Yves Dervaux, Orlane Desvouas, André Oursin, Dominique Quinzat, Roger Dachez, Christian Bathelier, Christophe Ronsin.   

Abstract

The commercial COBAS Amplicor CT/NG test (Roche Diagnostic Systems, Meylan, France) is a sensitive and specific method for detection of Chlamydia trachomatis infections. This test currently consists of using a nucleic acid amplification method to detect C. trachomatis in first-void urine specimens and in endocervical swabs collected in 2-sucrose-phosphate (2SP) transport medium. We conducted a prospective study to determine whether the automated COBAS Amplicor CT/NG test can detect C. trachomatis in cervical specimens collected in PreservCyt transport medium (ThinPrep Pap Test; Cytyc Corporation, Boxborough, Mass.). PreservCyt medium is used to preserve cervical samples before the preparation of ThinPrep slides. We collected 1,000 cervical specimens from young women (age range, 15 to 25 years) during routine Pap smear tests. Only specimens with normal cytology and in which the gynecologist found no clinical evidence of urogenital infections were selected. The samples were stored in PreservCyt transport medium at 15 to 20 degrees C. C. trachomatis was detected in 22 of the 1,000 cervical specimens that had been stored in PreservCyt. To confirm the positive samples, the test was repeated on new endocervical swab specimens collected in 2SP transport medium. Only 9 of the 22 positive patients agreed to undergo this control, but all 9 retested positive. To evaluate the influence of storage conditions on the sensitivity of the C. trachomatis PCR test, all of the positive samples were stored at 15 to 20 degrees C in PreservCyt transport medium and were retested every 2 weeks for 6 weeks. C. trachomatis was successfully amplified from all 22 specimens for the whole 6-week period. The prevalence of C. trachomatis infection was 2.2% in our study population. These results demonstrate that PreservCyt transport medium is a suitable transport medium for detection of C. trachomatis by the COBAS Amplicor CT/NG test. The ThinPrep Pap Test may enable gynecologists to monitor for both cervical lesions and C. trachomatis infections with a single endocervical specimen.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11980955      PMCID: PMC130670          DOI: 10.1128/JCM.40.5.1749-1754.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  45 in total

1.  HPV DNA testing of the residual sample of liquid-based Pap test: utility as a quality assurance monitor.

Authors:  R E Zuna; W Moore; S T Dunn
Journal:  Mod Pathol       Date:  2001-03       Impact factor: 7.842

Review 2.  Pap smears: screening, interpretation, treatment.

Authors:  S E Perlman
Journal:  Adolesc Med       Date:  1999-06

3.  Comparison of three commercially available amplification assays, AMP CT, LCx, and COBAS AMPLICOR, for detection of Chlamydia trachomatis in first-void urine.

Authors:  W H Goessens; J W Mouton; W I van der Meijden; S Deelen; T H van Rijsoort-Vos; N Lemmens-den Toom; H A Verbrugh; R P Verkooyen
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

Review 4.  Diagnosis of urogenital Chlamydia trachomatis infection by use of DNA amplification.

Authors:  L Ostergaard
Journal:  APMIS Suppl       Date:  1999

Review 5.  Current methods of laboratory diagnosis of Chlamydia trachomatis infections.

Authors:  C M Black
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

6.  Determination of Chlamydia trachomatis prevalence in an asymptomatic screening population: performances of the LCx and COBAS Amplicor tests with urine specimens.

Authors:  S A Morré; I G Van Valkengoed; R M Moes; A J Boeke; C J Meijer; A J Van den Brule
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

7.  Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis.

Authors:  B Van Der Pol; T C Quinn; C A Gaydos; K Crotchfelt; J Schachter; J Moncada; D Jungkind; D H Martin; B Turner; C Peyton; R B Jones
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

8.  Decreased prevalence of Chlamydia trachomatis infection associated with a selective screening program in family planning clinics in Wisconsin.

Authors:  D G Addiss; M L Vaughn; D Ludka; J Pfister; J P Davis
Journal:  Sex Transm Dis       Date:  1993 Jan-Feb       Impact factor: 2.830

9.  Multicenter evaluation of the fully automated COBAS AMPLICOR PCR test for detection of Chlamydia trachomatis in urogenital specimens.

Authors:  J Vincelette; J Schirm; M Bogard; A M Bourgault; D S Luijt; A Bianchi; P C van Voorst Vader; A Butcher; M Rosenstraus
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

10.  Diagnosis by AMPLICOR PCR of Chlamydia trachomatis infection in urine samples from women and men attending sexually transmitted disease clinics.

Authors:  T C Quinn; L Welsh; A Lentz; K Crotchfelt; J Zenilman; J Newhall; C Gaydos
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

View more
  7 in total

1.  Comparison of methods for detection of Chlamydia trachomatis and Neisseria gonorrhoeae using commercially available nucleic acid amplification tests and a liquid pap smear medium.

Authors:  Emilia H Koumans; Carolyn M Black; Lauri E Markowitz; ElizabethR Unger; Antonya Pierce; Mary K Sawyer; John R Papp
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

2.  Epidemiology of HPV in HIV-positive and HIV-negative fertile women in Cameroon, West Africa.

Authors:  Andrew J Desruisseau; Delf Schmidt-Grimminger; Edith Welty
Journal:  Infect Dis Obstet Gynecol       Date:  2010-02-09

3.  APTIMA assay on SurePath liquid-based cervical samples compared to endocervical swab samples facilitated by a real time database.

Authors:  Samer N Khader; Kathie Schlesinger; Josh Grossman; Richard I Henry; Mark Suhrland; Amy S Fox
Journal:  Cytojournal       Date:  2010-07-02       Impact factor: 2.091

4.  Liquid based cytology: examination of its potential in a chlamydia screening programme.

Authors:  J Hopwood; H Mallinson; E Hodgson; L Hull
Journal:  Sex Transm Infect       Date:  2004-10       Impact factor: 3.519

5.  Abilities of APTIMA, AMPLICOR, and ProbeTec assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in PreservCyt ThinPrep Liquid-based Pap samples.

Authors:  M Chernesky; D Jang; E Portillo; S Chong; M Smieja; K Luinstra; A Petrich; C Macritchie; R Ewert; B Hayhoe; A Sarabia; F Thompson
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

6.  Detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in North American women by testing SurePath liquid-based Pap specimens in APTIMA assays.

Authors:  Max Chernesky; Gregory G Freund; Edward Hook; Peter Leone; Peter D'Ascoli; Mark Martens
Journal:  J Clin Microbiol       Date:  2007-06-20       Impact factor: 5.948

7.  Efficiency of an inexpensive liquid-based cytology performed by cytocentrifugations: a comparative study using the histology as reference standard.

Authors:  Christian Garbar; Corinne Mascaux; Véronique Fontaine
Journal:  Cytojournal       Date:  2005-09-15       Impact factor: 2.091

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.